ArticleBMJ open diabetes research & care2019

Eligibility of patients with type 2 diabetes for sodium-glucose cotransporter 2 inhibitor cardiovascular outcomes trials: a global perspective from the DISCOVER study.

Stéphane Pintat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.